Total Visits

Views
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database60

Select a period of time:

Views

Views
April 20252
May 202510
June 20250
July 202510
August 20250
September 20250
October 20255
Download CSV file
 untranslated
 untranslated

Top country views

Views
Hong Kong10
Brazil6
United States5
South Africa2
Ecuador1
Spain1
Ethiopia1
Tunisia1
 

Top cities views

Views
Hong Kong10
Addis Ababa1
Caratinga1
Council Bluffs1
Durban1
Guayaquil1
Ipatinga1
Johannesburg1
Korba1
Marília1